About Butterfly Therapeutics
Butterfly Therapeutics is a company based in Laval (Canada) founded in 2017 by Melanie Peron. It operates as a B2B and D2C. Butterfly Therapeutics offers products and services including Bliss DTx and Endocare. Butterfly Therapeutics operates in a competitive market with competitors including HELP Mee Pain Therapy, re|mappable, Signalic and Curonix, among others.
- Headquarter Laval, Canada
- Founders Melanie Peron
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Butterfly Therapeutics
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Butterfly Therapeutics
Butterfly Therapeutics offers a comprehensive portfolio of products and services, including Bliss DTx and Endocare.
Software using virtual reality to reduce pain and anxiety during medical procedures.
Software for relieving chronic pelvic pain in endometriosis patients.
Funding Insights of Butterfly Therapeutics
Detailed funding history for Butterfly Therapeutics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Butterfly Therapeutics
Investment portfolio details for Butterfly Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Butterfly Therapeutics
Detailed financials for Butterfly Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Butterfly Therapeutics Comparisons
Peer comparison for Butterfly Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Butterfly Therapeutics
Butterfly Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HELP Mee Pain Therapy, re|mappable, Signalic and Curonix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A digital therapy course for chronic pain management is offered.
|
|
| Locked | Locked | Locked |
Augmented reality platform is offered for clinical pain reduction therapies.
|
|
| Locked | Locked | Locked |
Creates AI-driven systems to predict and manage chronic pain risks for healthcare providers.
|
|
| Locked | Locked | Locked |
Develops implantable systems for treating chronic pain through peripheral nerve stimulation.
|
Detailed competitors of Butterfly Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Butterfly Therapeutics
Complete news archive for Butterfly Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Butterfly Therapeutics
Butterfly Therapeutics was founded in 2017.
Butterfly Therapeutics is headquartered in Laval, Canada. It is registered at Laval, Quebec, Canada.
Butterfly Therapeutics creates digital therapies based on clinically validated protocols to manage acute and chronic pain without relying on chemicals alone. They develop software like Bliss DTx for reducing pain during medical procedures and Endocare for endometriosis-related pain. Located in Laval, France, their solutions complement pharmacological treatments, serving healthcare providers and patients by offering virtual reality-based alternatives that minimize side effects and dependencies.
Butterfly Therapeutics's top competitors include HELP Mee Pain Therapy, re|mappable and Signalic.
Butterfly Therapeutics offers Bliss DTx and Endocare.